BIOGEN INC. 10-Q filing
Filed 2026-04-29 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0000875045-26-000045
- Form type
- 10-Q
- CIK
- 0000875045
- Primary document
- https://www.sec.gov/Archives/edgar/data/875045/000087504526000045/biib-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOGEN INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $2.5B | - | - |
| Cost Of Revenue | $661.0M | - | - |
| Net Income | $319.5M | - | - |
| Eps Basic | 2.17 | - | - |
| Eps Diluted | 2.15 | - | - |
| Total Assets | $29.5B | - | - |
| Total Liabilities | $10.8B | - | - |
| Operating Cash Flow | $645.5M | - | - |
| Capital Expenditures | $51.2M | - | - |